Literature DB >> 12829804

Disruption of a receptor-mediated mechanism for intracellular sorting of proinsulin in familial hyperproinsulinemia.

Savita Dhanvantari1, Fu-Sheng Shen, Tiffany Adams, Christopher R Snell, ChunFa Zhang, Robert B Mackin, Stephen J Morris, Y Peng Loh.   

Abstract

In familial hyperproinsulinemia, specific mutations in the proinsulin gene are linked with a profound increase in circulating plasma proinsulin levels. However, the molecular and cellular basis for this disease remains uncharacterized. Here we investigated how these mutations may disrupt the sorting signal required to target proinsulin to the secretory granules of the regulated secretory pathway, resulting in the unregulated release of proinsulin. Using a combination of molecular modeling and site-directed mutagenesis, we have identified structural molecular motifs in proinsulin that are necessary for correct sorting into secretory granules of endocrine cells. We show that membrane carboxypeptidase E (CPE), previously identified as a prohormone-sorting receptor, is essential for proinsulin sorting. This was demonstrated through short interfering RNA-mediated depletion of CPE and transfection with a dominant negative mutant of CPE in a beta-cell line. Mutant proinsulins found in familial hyperproinsulinemia failed to bind to CPE and were not sorted efficiently. These findings provide evidence that the elevation of plasma proinsulin levels found in patients with familial hyperproinsulinemia is caused by the disruption of CPE-mediated sorting of mutant proinsulins to the regulated secretory pathway.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12829804     DOI: 10.1210/me.2002-0380

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  21 in total

Review 1.  New roles of carboxypeptidase E in endocrine and neural function and cancer.

Authors:  Niamh X Cawley; William C Wetsel; Saravana R K Murthy; Joshua J Park; Karel Pacak; Y Peng Loh
Journal:  Endocr Rev       Date:  2012-03-07       Impact factor: 19.871

2.  Systematic determination of differential gene expression in the primate corpus luteum during the luteal phase of the menstrual cycle.

Authors:  Randy L Bogan; Melinda J Murphy; Richard L Stouffer; Jon D Hennebold
Journal:  Mol Endocrinol       Date:  2008-02-07

Review 3.  How peptide hormone vesicles are transported to the secretion site for exocytosis.

Authors:  Joshua J Park; Y Peng Loh
Journal:  Mol Endocrinol       Date:  2008-07-31

4.  Two dipolar α-helices within hormone-encoding regions of proglucagon are sorting signals to the regulated secretory pathway.

Authors:  Leonardo Guizzetti; Rebecca McGirr; Savita Dhanvantari
Journal:  J Biol Chem       Date:  2014-04-11       Impact factor: 5.157

Review 5.  POMC: The Physiological Power of Hormone Processing.

Authors:  Erika Harno; Thanuja Gali Ramamoorthy; Anthony P Coll; Anne White
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

6.  Overexpression of CPE-ΔN predicts poor prognosis in colorectal cancer patients.

Authors:  Kun Zhou; Hongyan Liang; Yang Liu; Chun Yang; Peijia Liu; Xiaofeng Jiang
Journal:  Tumour Biol       Date:  2013-07-14

7.  Toward gene therapy for growth hormone deficiency via salivary gland expression of growth hormone.

Authors:  G Z Racz; C Zheng; C M Goldsmith; B J Baum; N X Cawley
Journal:  Oral Dis       Date:  2014-01-13       Impact factor: 3.511

8.  Carboxypeptidase E and Secretogranin III Coordinately Facilitate Efficient Sorting of Proopiomelanocortin to the Regulated Secretory Pathway in AtT20 Cells.

Authors:  Niamh X Cawley; Trushar Rathod; Sigrid Young; Hong Lou; Nigel Birch; Y Peng Loh
Journal:  Mol Endocrinol       Date:  2015-12-08

9.  tRNA gene copy number variation in humans.

Authors:  James R Iben; Richard J Maraia
Journal:  Gene       Date:  2013-12-14       Impact factor: 3.688

10.  Secretory granule biogenesis and neuropeptide sorting to the regulated secretory pathway in neuroendocrine cells.

Authors:  Y Peng Loh; Taeyoon Kim; Yazmin M Rodriguez; Niamh X Cawley
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.